Event
Entity
Entity
Process
Occurrent
Occurrent
2025-05-07T23:10:45
RDF description of ASCO (American Society of Clinical Oncology) 2025 Annual Meeting - http://repository.healthpartners.com/individual/conference-ASCO--American-Society-of-Clinical-Oncology--2025-Annual-Meeting
ASCO (American Society of Clinical Oncology) 2025 Annual Meeting
2025-01-31T22:52:05.028-06:00
Chicago, IL
α): the REFRaME-L1 phase 2 study
[presentation]
Efficacy and safety of luveltamab tazevibulin in patients (pts) with advanced, previously treated non-small cell lung cancer (NSCLC) expressing folate receptor alpha (FR
public